MCED white paper
MCED accelerates despite hurdles
New survey insights from Becker's Healthcare reveal why multi-cancer early detection (MCED) adoption is accelerating, ways to address MCED integration, and how health systems across the country are using these tests to position themselves for strategic advantage.
Discover the shift to MCED
- Learn why nearly 60% of health systems surveyed are already offering or are planning to offer MCED in the next year
- See what’s driving health systems to act: from earlier detection to improved patient experience, and value-based goals
See how peers navigate the transition
Conducted by Becker’s Healthcare and Exact Sciences, the 101 survey respondents include:
- C-suite executives (CEOs, CMOs and CFOs)
- Directors of population health from large hospital systems
Interested in learning more?
Cancerguard® for health systems
Learn more about how the Cancerguard test works and how it can help transform your cancer screening program.
Provider information and resources
Get more information on the Cancerguard test and how it can help you detect cancer earlier.
Continue the conversation
Reach out to see how we can support your goals in early cancer detection and diagnosis.